Mitsugu Sekimoto Selected Research

Mitsugu Sekimoto Research Topics

Disease

114	Neoplasms (Cancer) 04/2024 - 11/2002
48	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 06/2002
46	Neoplasm Metastasis (Metastasis) 04/2024 - 06/2002
30	Rectal Neoplasms (Rectal Cancer) 02/2024 - 10/2003
23	Stomach Neoplasms (Stomach Cancer) 12/2021 - 01/2003
17	Lymphatic Metastasis 10/2023 - 06/2002
15	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 05/2003
14	Adenocarcinoma 12/2023 - 08/2003
13	Colonic Neoplasms (Colon Cancer) 01/2018 - 05/2005
11	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 03/2008
9	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2010
9	Carcinoma (Carcinomatosis) 06/2023 - 03/2008
8	Hemorrhage 08/2021 - 11/2003
7	Triple Negative Breast Neoplasms 06/2022 - 01/2020
5	Inflammation (Inflammations) 01/2024 - 01/2022
5	Cholangiocarcinoma 01/2023 - 04/2010
5	Esophageal Neoplasms (Esophageal Cancer) 04/2021 - 01/2008
5	Diarrhea 01/2021 - 11/2006
5	Venous Thromboembolism 09/2019 - 11/2014
4	Ischemia 05/2024 - 07/2021
4	Reperfusion Injury 05/2024 - 12/2022
4	Hypoxia (Hypoxemia) 01/2022 - 04/2006
4	Pain (Aches) 01/2022 - 10/2003
4	Neutropenia 05/2016 - 01/2013
3	Sepsis (Septicemia) 01/2023 - 01/2022
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 08/2006
3	Anemia 01/2023 - 12/2018
3	Postoperative Pain 11/2022 - 10/2013
3	Pathologic Constriction (Stenosis) 11/2022 - 04/2021
3	Sigmoid Neoplasms 12/2019 - 11/2010
3	Wounds and Injuries (Trauma) 12/2019 - 11/2003
3	Margins of Excision 10/2019 - 01/2012
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2016 - 03/2008
3	Thrombosis (Thrombus) 05/2009 - 02/2005
3	Adenoma (Adenomas) 02/2008 - 11/2002

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 04/2022 - 06/2002
16	Irinotecan (Camptosar)FDA LinkGeneric 12/2018 - 10/2004
11	Messenger RNA (mRNA)IBA 01/2024 - 08/2003
10	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2004
9	Leucovorin (Folinic Acid)FDA Link 01/2018 - 10/2005
8	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023 - 08/2005
7	Gemcitabine FDA Link 07/2023 - 01/2018
7	Bevacizumab (Avastin)FDA Link 09/2021 - 01/2013
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 08/2005
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2006
6	Fondaparinux (Arixtra)FDA Link 09/2019 - 11/2014
6	TegafurIBA 01/2018 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2016
5	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 10/2005
5	UracilIBA 01/2018 - 01/2006
4	RNA (Ribonucleic Acid)IBA 09/2022 - 02/2004
4	Trastuzumab (Herceptin)FDA Link 12/2018 - 11/2014
3	LigandsIBA 01/2024 - 04/2022
3	C-Reactive ProteinIBA 07/2023 - 10/2013
3	AlbuminsIBA 07/2023 - 04/2022
3	Immune Checkpoint InhibitorsIBA 02/2023 - 09/2021
3	CarbohydratesIBA 01/2023 - 05/2012
3	BilirubinIBA 10/2022 - 11/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 11/2014
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 02/2010
3	Perilipin-2IBA 04/2022 - 01/2020
3	130-nm albumin-bound paclitaxelIBA 02/2022 - 01/2018
3	B7-H1 AntigenIBA 03/2021 - 01/2021
3	Capecitabine (Xeloda)FDA Link 12/2019 - 02/2008
3	AnticoagulantsIBA 09/2019 - 02/2005
3	Carcinoembryonic AntigenIBA 01/2016 - 06/2002
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011 - 02/2004
3	Calcibiotic Root Canal SealerIBA 11/2010 - 02/2008
3	Complementary DNA (cDNA)IBA 12/2008 - 01/2007
3	Cyclin D1IBA 08/2006 - 11/2002
2	EnzymesIBA 05/2024 - 04/2022
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2024 - 01/2023
2	CytokinesIBA 01/2024 - 12/2022
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2024 - 01/2021
2	Photosensitizing Agents (Photosensitizers)IBA 01/2024 - 09/2022

Therapy/Procedure

51	Therapeutics 04/2024 - 10/2002
49	Drug Therapy (Chemotherapy) 04/2024 - 08/2006
17	Neoadjuvant Therapy 03/2024 - 01/2011
16	Gastrectomy 08/2021 - 01/2003
15	Adjuvant Chemotherapy 06/2022 - 10/2004
14	Hepatectomy 05/2024 - 12/2010
14	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2003
11	Radiotherapy 07/2023 - 11/2006
8	Laparotomy 12/2023 - 09/2014
8	Pancreatectomy 11/2022 - 11/2015
7	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 10/2004
6	Pancreaticoduodenectomy 11/2022 - 11/2015
5	Colectomy 10/2023 - 04/2014
4	Heavy Ion Radiotherapy 02/2024 - 01/2016
4	Chemoradiotherapy 07/2023 - 11/2016
4	Aftercare (After-Treatment) 06/2022 - 11/2014
4	Combined Modality Therapy 02/2022 - 11/2015
4	Pelvic Exenteration 01/2022 - 11/2011
4	Operative Surgical Procedures 08/2021 - 01/2017
4	Proctectomy 11/2017 - 10/2003
3	Immunotherapy 06/2022 - 02/2010
3	Segmental Mastectomy (Lumpectomy) 03/2020 - 11/2016
3	Oral Administration 12/2018 - 03/2010
3	Restorative Proctocolectomy 11/2016 - 03/2008
3	Splenectomy 05/2009 - 02/2005